{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:12:52Z","timestamp":1790903572072,"version":"4.1.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Mature T-cell lymphomas represent neoplastic expansions of T-cell lymphocytes with a post-thymic derivation. Most of these tumors feature aggressive clinical behavior and challenging histopathological diagnosis and classification. Novel findings in the genomic landscape of T-cell lymphomas are helping to improve the understanding of the biology and the molecular mechanisms that underly its clinical behavior. The most recent WHO-HAEM5 classification of hematolymphoid tumors introduced novel molecular and histopathological findings that will aid in the diagnostic classification of this group of neoplasms. The current review article summarizes the most relevant diagnostic features of peripheral T-cell lymphomas with an emphasis on the updates that are incorporated at the WHO-HAEM5.<\/jats:p>","DOI":"10.3389\/fonc.2022.1099265","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T08:19:53Z","timestamp":1671524393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates"],"prefix":"10.3389","volume":"12","author":[{"given":"Carlos","family":"Murga-Zamalloa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar","family":"Inamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-319-99716-2_4","article-title":"Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)","volume":"176","author":"Oluwasanjo","year":"2019","journal-title":"Cancer Treat Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-692566","article-title":"Peripheral T-cell lymphoma, not otherwise specified","volume":"129","author":"Broccoli","year":"2017","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(20)30474-2","article-title":"Pathology and pathogenesis of T-cell lymphoma","author":"Vega","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11899-016-0353-y","article-title":"T-Cell lymphoma epidemiology: the known and unknown","volume":"11","author":"Phan","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000500666","article-title":"Outcomes for relapsed and refractory peripheral T-cell lymphoma patients after front-line therapy from the COMPLETE registry","volume":"143","author":"Lansigan","year":"2020","journal-title":"Acta Haematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24791","article-title":"The aggressive peripheral T-cell lymphomas: 2017","volume":"92","author":"Armitage","year":"2017","journal-title":"Am J Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0002","article-title":"A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories","volume":"104","author":"Herling","year":"2004","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-380139","article-title":"How I treat prolymphocytic leukemia","volume":"120","author":"Dearden","year":"2012","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1339880","article-title":"Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL)","volume":"59","author":"Sanikommu","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0644-0","article-title":"Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients","volume":"34","author":"Barila","year":"2020","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/GO.21.00084","article-title":"Real-world data on adult T-cell Leukemia\/Lymphoma in Latin America: A study from the grupo de estudio latinoamericano de linfoproliferativos","volume":"7","author":"Malpica","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10480","article-title":"Adult T-cell leukemia\/lymphoma: a cytopathologic, immunocytochemical, and flow cytometric study","volume":"96","author":"Dahmoush","year":"2002","journal-title":"Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0037-3","article-title":"Adult T-cell leukemia\/lymphoma can be indistinguishable from other more common T-cell lymphomas. the university of Miami experience with a large cohort of cases","volume":"31","author":"Khanlari","year":"2018","journal-title":"Mod Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0635-8","article-title":"A new diagnostic algorithm using biopsy specimens in adult T-cell leukemia\/lymphoma: combination of RNA in situ hybridization and quantitative PCR for HTLV-1","volume":"34","author":"Takatori","year":"2021","journal-title":"Mod Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41408-017-0021-z","article-title":"Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes","volume":"7","author":"Tang","year":"2017","journal-title":"Blood Cancer J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/s41467-018-03987-2","article-title":"Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target","volume":"9","author":"Dufva","year":"2018","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-385559","article-title":"How I treat enteropathy-associated T-cell lymphoma","volume":"119","author":"Di Sabatino","year":"2012","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2010","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.295","article-title":"Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma","volume":"25","author":"Tan","year":"2011","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2058738419829387","DOI":"10.1177\/2058738419829387","article-title":"Monomorphic epitheliotropic intestinal T-cell lymphoma may mimic intestinal inflammatory disorders","volume":"33","author":"Tian","year":"2019","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.41","article-title":"(epitheliotropic intestinal T-cell lymphoma): A neoplasm of intra-epithelial T-cells with predominant CD8alphaalpha phenotype","volume":"27","author":"Tan","year":"2013","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03791-y","article-title":"Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma","volume":"98","author":"Yi","year":"2019","journal-title":"Ann Hematol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13000-022-01237-0","article-title":"CD30 + primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report","volume":"17","author":"Osmani","year":"2022","journal-title":"Diagn Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.20020","article-title":"Intestinal T-cell lymphoma, NOS, presenting with sole peritoneal and mucosal lymphomatosis throughout abdominal cavity","volume":"60","author":"Watanabe-Okochi","year":"2020","journal-title":"J Clin Exp Hematop"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.45","article-title":"Primary intestinal T-cell and NK-cell lymphomas: A clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma","volume":"24","author":"Sun","year":"2011","journal-title":"Mod Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2018.10.004","article-title":"Intestinal T-cell and NK\/T-cell lymphomas: A clinicopathological study of 27 Chinese patients","volume":"37","author":"Tang","year":"2018","journal-title":"Ann Diagn Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-512830","article-title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"122","author":"Perry","year":"2013","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2019.10.001","article-title":"T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: Review and update","volume":"52","author":"van Vliet","year":"2020","journal-title":"Pathology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/hon.2317","article-title":"Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: A review and update","volume":"35","author":"Matnani","year":"2017","journal-title":"Hematol Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/1066896918785985","article-title":"Disease progression in a patient with indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"27","author":"Perry","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230961","article-title":"Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract","volume":"105","author":"Soderquist","year":"2020","journal-title":"Haematologica"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302737","article-title":"NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series","volume":"117","author":"Mansoor","year":"2011","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ajcp\/aqy108","article-title":"NK-cell enteropathy and similar indolent lymphoproliferative disorders: A case series with literature review","volume":"151","author":"Xia","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001443","article-title":"Recurrent somatic JAK3 mutations in NK-cell enteropathy","volume":"134","author":"Xiao","year":"2019","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"100126","DOI":"10.1016\/j.lanwpc.2021.100126","article-title":"Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia","volume":"10","author":"Yoon","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2020.05.006","article-title":"A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes","volume":"102","author":"Vega","year":"2020","journal-title":"Hum Pathol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.366","article-title":"NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma","volume":"36","author":"Murga-Zamalloa","year":"2017","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-482026","article-title":"Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma","volume":"122","author":"McDonnell","year":"2013","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/PGPM.S37504","article-title":"ALK-driven tumors and targeted therapy: focus on crizotinib","volume":"7","author":"Murga-Zamalloa","year":"2014","journal-title":"Pharmgenomics Pers Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: A Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01093-1","article-title":"STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma","volume":"35","author":"Lobello","year":"2021","journal-title":"Leukemia"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1038\/s41467-021-25379-9","article-title":"Super-enhancer-based identification of a BATF3\/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma","volume":"12","author":"Liang","year":"2021","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000001708","article-title":"JAK2 rearrangements are a recurrent alteration in CD30+ systemic T-cell lymphomas with anaplastic morphology","volume":"45","author":"Fitzpatrick","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","article-title":"Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic Large cell lymphoma","volume":"42","author":"Ferrufino-Schmidt","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic Large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant-associated anaplastic large cell lymphoma","volume":"132","author":"Oishi","year":"2018","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001904","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.humpath.2018.04.007","article-title":"IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis","volume":"78","author":"Kadin","year":"2018","journal-title":"Hum Pathol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.immuni.2015.08.020","article-title":"Induction of interleukin-9-Producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy","volume":"43","author":"Chen","year":"2015","journal-title":"Immunity"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.4.1373","article-title":"Activated mast cells produce interleukin 13","volume":"181","author":"Burd","year":"1995","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.05.007","article-title":"Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas","volume":"90","author":"Tabanelli","year":"2019","journal-title":"Hum Pathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","article-title":"How I diagnose angioimmunoblastic T-cell lymphoma","volume":"156","author":"Xie","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2015.03.008","article-title":"Follicular helper T-cell lymphoma: a b-cell-rich variant of T-cell lymphoma","volume":"19","author":"Ruiz","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.humpath.2021.07.012","article-title":"Incidence and clinicopathological features of follicular T-cell lymphoma in Finland: a population-based immunohistochemical study","volume":"117","author":"Kiiskila","year":"2021","journal-title":"Hum Pathol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_486_19","article-title":"Follicular T-cell lymphoma","volume":"17","author":"Lisa","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010991","article-title":"The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation","volume":"95","author":"Marafioti","year":"2010","journal-title":"Haematologica"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001315","article-title":"Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype","volume":"43","author":"Basha","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"JCO2102707","DOI":"10.1200\/JCO.21.02707","article-title":"Gene expression signatures for the accurate diagnosis of peripheral T-cell lymphoma entities in the routine clinical practice","author":"Amador","year":"2022","journal-title":"J Clin Oncol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12981","article-title":"RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases","volume":"70","author":"Miyoshi","year":"2020","journal-title":"Pathol Int"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11673","article-title":"GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1996","article-title":"T-Cell receptor signaling activates an ITK\/NF-kappaB\/GATA-3 axis in T-cell lymphomas facilitating resistance to chemotherapy","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-544809","article-title":"GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41408-022-00745-y","article-title":"GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms","volume":"12","author":"Geng","year":"2022","journal-title":"Blood Cancer J"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2130","article-title":"GATA-3 in T-cell lymphoproliferative disorders","volume":"72","author":"Murga-Zamalloa","year":"2020","journal-title":"IUBMB Life"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24203","article-title":"A three-signal model of T-cell lymphoma pathogenesis","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-220111","article-title":"Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061414","article-title":"EBV and the pathogenesis of NK\/T cell lymphoma","volume":"13","author":"Montes-Mojarro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.24.5.1165","article-title":"Clinicopathological states of Epstein-Barr virus-associated T\/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults","volume":"24","author":"Suzuki","year":"2004","journal-title":"Int J Oncol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20398","article-title":"Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection","volume":"80","author":"Okano","year":"2005","journal-title":"Am J Hematol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.semdp.2019.12.004","article-title":"Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis","volume":"37","author":"Montes-Mojarro","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-785931","article-title":"How I treat T-cell chronic active Epstein-Barr virus disease","volume":"131","author":"Bollard","year":"2018","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001451","article-title":"Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification","volume":"4","author":"Yonese","year":"2020","journal-title":"Blood Adv"},{"key":"B85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson cancer center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1177\/106689690401200410","article-title":"Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800157","article-title":"Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore","volume":"17","author":"Ng","year":"2004","journal-title":"Mod Pathol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta\/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-829424","article-title":"Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma","volume":"132","author":"Song","year":"2018","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007247","article-title":"Avelumab for the treatment of relapsed or refractory extranodal NK\/T-cell lymphoma: an open-label phase 2 study","volume":"136","author":"Kim","year":"2020","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr Virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2068-1","article-title":"Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma","volume":"104","author":"Jung","year":"2016","journal-title":"Int J Hematol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.03.002","article-title":"Hematopathology study group of the Korean society of p. Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features","volume":"46","author":"Jeon","year":"2015","journal-title":"Hum Pathol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.02997.x","article-title":"Nodal T\/NK-cell lymphoma of nasal type: a clinicopathological study of six cases","volume":"52","author":"Takahashi","year":"2008","journal-title":"Histopathology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280003","article-title":"Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS","volume":"107","author":"Wai","year":"2022","journal-title":"Haematologica"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25674","article-title":"Incidence and outcomes of rare T cell lymphomas from the T cell project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas","volume":"95","author":"Foss","year":"2020","journal-title":"Am J Hematol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: Report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1309\/YTTC-F55W-K9CP-EPX5","article-title":"Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients","volume":"113","author":"Wu","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1309\/BM40-YM6J-9T3X-MH8H","article-title":"Hepatosplenic gamma\/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features","volume":"116","author":"Vega","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenic T-cell lymphoma: Clinicopathologic study of 28 cases","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. a review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discovery"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1099265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T08:19:57Z","timestamp":1671524397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1099265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":107,"alternative-id":["10.3389\/fonc.2022.1099265"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1099265","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"article-number":"1099265"}}